1. Home
  2. IQV vs TW Comparison

IQV vs TW Comparison

Compare IQV & TW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • TW
  • Stock Information
  • Founded
  • IQV 1982
  • TW 1996
  • Country
  • IQV United States
  • TW United States
  • Employees
  • IQV N/A
  • TW N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • TW Investment Bankers/Brokers/Service
  • Sector
  • IQV Health Care
  • TW Finance
  • Exchange
  • IQV Nasdaq
  • TW Nasdaq
  • Market Cap
  • IQV 31.6B
  • TW 28.4B
  • IPO Year
  • IQV 2013
  • TW 2019
  • Fundamental
  • Price
  • IQV $177.31
  • TW $146.77
  • Analyst Decision
  • IQV Strong Buy
  • TW Strong Buy
  • Analyst Count
  • IQV 18
  • TW 14
  • Target Price
  • IQV $248.72
  • TW $137.23
  • AVG Volume (30 Days)
  • IQV 1.5M
  • TW 1.0M
  • Earning Date
  • IQV 05-01-2025
  • TW 04-30-2025
  • Dividend Yield
  • IQV N/A
  • TW 0.33%
  • EPS Growth
  • IQV 2.74
  • TW 36.26
  • EPS
  • IQV 7.49
  • TW 2.33
  • Revenue
  • IQV $15,405,000,000.00
  • TW $1,721,670,000.00
  • Revenue This Year
  • IQV $4.30
  • TW $22.32
  • Revenue Next Year
  • IQV $6.17
  • TW $11.73
  • P/E Ratio
  • IQV $23.68
  • TW $63.00
  • Revenue Growth
  • IQV 2.81
  • TW 28.85
  • 52 Week Low
  • IQV $176.03
  • TW $98.93
  • 52 Week High
  • IQV $253.84
  • TW $147.42
  • Technical
  • Relative Strength Index (RSI)
  • IQV 35.22
  • TW 72.70
  • Support Level
  • IQV $180.00
  • TW $140.47
  • Resistance Level
  • IQV $188.39
  • TW $147.42
  • Average True Range (ATR)
  • IQV 4.58
  • TW 3.11
  • MACD
  • IQV -0.35
  • TW 0.71
  • Stochastic Oscillator
  • IQV 9.22
  • TW 95.72

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

Share on Social Networks: